- PRESS RELEASE
Consolidated financial statement of the Eurosystem as at 9 August 2024
13 August 2024
In the week ending 9 August 2024 the net position of the Eurosystem in foreign currency (asset items 2 and 3 minus liability items 7, 8 and 9) increased by EUR 0.3 billion to EUR 325.8 billion.
The net balance of open market operations and standing facilities (asset item 5 minus liability items 2.2, 2.3, 2.4, 2.5 and 4) decreased by EUR 25.9 billion to ‑EUR 3,000.1 billion. This was due primarily to the change in the level of the deposit facility (liability item 2.2).
Base money (liability items 1, 2.1 and 2.2) increased by EUR 20.4 billion to EUR 4,811.2 billion.
The table below provides the detailed breakdown of securities held for monetary policy purposes (asset item 7.1) into the different portfolios. All portfolios are accounted for at amortised cost.
Table 1
Monetary policy securities portfolios | Reported value as at 9 August 2024 | Weekly change – purchases [1] | Weekly change – redemptions |
Securities Markets Programme | EUR 1.3 billion | - | - |
Covered bond purchase programme 3 | EUR 262.4 billion | - | - |
Asset-backed securities purchase programme | EUR 8.6 billion | - | -EUR 0.0 billion |
Public sector purchase programme | EUR 2,227.2 billion | - | -EUR 0.1 billion |
Corporate sector purchase programme | EUR 303.0 billion | - | - |
Pandemic emergency purchase programme | EUR 1,652.7 billion | +EUR 0.6 billion | -EUR 0.0 billion |
[1] With the discontinuation of the reinvestments under the asset purchase programme, this column may sometimes show negative amounts. These are expected to be infrequent and would result from sales of securities conducted, for instance, for risk management purposes.
The content and format of the weekly financial statement are set out in Annexes IV to VI of Guideline (EU) 2016/2249 of the European Central Bank of 3 November 2016 on the legal framework for accounting and financial reporting in the European System of Central Banks (ECB/2016/34).
Den Europæiske Centralbank
Generaldirektoratet Kommunikation
- Sonnemannstrasse 20
- 60314 Frankfurt am Main, Tyskland
- +49 69 1344 7455
- media@ecb.europa.eu
Eftertryk tilladt med kildeangivelse.
Pressekontakt